Ajanta Pharma share news, announcements and annual reports
NSE: AJANTPHARMBSE: 532331Pharmaceuticals & BiotechnologyMid Cap
Ajanta Pharma Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2000 on NSE, Jun 2000 on BSE
Last close ₹3,508.80up ₹49.10 (1.42%)BSE ₹3,512.40
Share price at the NSE close on 30 Oct 2026. Previous close ₹3,459.70.
30 Oct: open ₹3,479.00, high ₹3,619.90, low ₹3,460.50
52-week range of traded prices to 30 Oct 2026
₹2,430.00Low, 30 Oct 2025₹3,796.00High, 18 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹43,846 Cr236th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 34.72
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.02
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.71%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 30.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 9,52,55826.6% delivered
Ajanta Pharma dividends
30 filed, newest first.
Oct 2024
Jan 2024
Jul 2023
Nov 2022
3 Nov · Dividend
Nov 2020
Nov 2019
Oct 2018
May 2018
Mar 2017
Oct 2016
Mar 2016
Jun 2015
May 2015
8 May · Dividend
Board of Directors of the Company at its meeting held on May 8, 2015, have recommended dividend @ Rs. 6/- per equity share on the face value of Rs. 2/- each, subject to approval of shareholders at the ensuing Annual General Meeting to be held in 2015.
Jul 2014
9 Jul · Dividend
Subject to approval of the shareholders at the forthcoming Annual General Meeting, the date of payment of dividend on equity shares would be on or after August 05, 2014.
May 2014
5 May · Dividend
Board of Directors of the Company at its meeting held on May 05, 2014 have recommended dividend @ Rs.10/-per equity share on the face value of Rs.5/- each, subject to approval of shareholders at the ensuing Annual General Meeting to held in 2014.
Jun 2013
6 Jun · Dividend
Ajanta Pharma Limited had informed the Exchange that the date of payment of dividend on equity shares would be on after July 26, 2013, subject to approval of the shareholders at the forthcoming Annual General meeting. The Company has now informed the Exchange that subject to approval of the shareholders at the forthcoming Annual General Meeting, the date of payment of dividend on equity shares would be on or after July 29, 2013.
May 2013
21 May · Dividend
Date of payment of dividend on equity shares would be on after July 26, 2013, subject to approval of the shareholders at the forthcoming Annual General meeting.
Apr 2013
30 Apr · Dividend
That the Board of Directors of the Company at its meeting held on April 30, 2013 have recommended dividend @ Rs. 6.25 per equity share of the face value of Rs. 5/- each, subject to approval of shareholders at the ensuing Annual General Meeting to be held on July 13, 2013.
May 2012
11 May · Dividend
Date of payment of dividend on equity shares would be on or after July 7, 2012, subject to approval of the shareholders at the forthcoming Annual General Meeting.
Apr 2012
27 Apr · Dividend
Board of Directors of the Company at its meeting held on April 26, 2012, have recommended dividend @ Rs. 7.50 per equity share of the face value of Rs. 10/- each, subject to approval of shareholders at the ensuing Annual General Meeting to be held on July 07, 2012.Further, the Board of Directors of the Company have also approved sub-division of nominal value of equity shares of the Company from Rs. 10/- each to nominal value of Rs. 5/- each, subject to approval of Members at the ensuing Annual General Meeting (AGM) of the Company.
May 2011
12 May · Dividend
Date of payment of dividend on equity shares would be on or after July 01, 2011, subject to approval of the shareholders at the forthcoming Annual General Meeting.
Apr 2011
30 Apr · Dividend
Board of Directors of the Company at its meeting held on April 30, 2011, have recommended the dividend @ Rs. 5/- per share, subject to the approval of the shareholders at the ensuing Annual General Meeting.
May 2010
6 May · Dividend
Board of Directors, at their meeting held on May 06, 2010, have recommended the dividend @ Rs. 3.50 per share, subject to the approval of the shareholders at the ensuing Annual General Meeting to be held on July 09, 2010.
Jun 2009
23 Jun · Dividend
Date of payment of dividend on equity shares would be on or after July 18, 2009, if it is approved by the shareholders at the forthcoming Annual General Meeting.
Jun 2008
18 Jun · Dividend
The date of payment of dividend on equity shares would be on or after July 08, 2008, if it is approved by shareholders at the forthcoming Annual General Meeting.
Sep 2007
20 Sep · Dividend
The date of payment of dividend on equity shares would be on or after 28th September, 2007, if it is approved by the shareholders at the forthcoming Annual General Meeting